(1(R)3)-b-D-glucan in patients with pulmonary aspergilloma
1997

Study on (1(R)3)-b-D-glucan in Pulmonary Aspergilloma

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Kazumi Yuasa, Hajime Goto

Primary Institution: Tokyo Metropolitan Komagome General Hospital

Hypothesis

What is the role of (1(R)3)-b-D-glucan in pulmonary aspergilloma?

Conclusion

The (1(R)3)-b-D-glucan assay may provide valuable data for evaluating disease activity in pulmonary aspergilloma.

Supporting Evidence

  • Patients were classified into three groups based on (1(R)3)-b-D-glucan levels and disease activity.
  • Increased (1(R)3)-b-D-glucan values might indicate early invasion of Aspergillus into surrounding tissue.
  • Concentrations of (1(R)3)-b-D-glucan were measured daily in one patient to assess day-to-day variation.

Takeaway

This study looked at a substance called (1(R)3)-b-D-glucan in patients with a lung disease caused by a fungus, to see if it could help understand how active the disease is.

Methodology

Serum concentrations of (1(R)3)-b-D-glucan were measured repeatedly for up to 10 months in eight patients.

Limitations

Further follow-up studies are required to verify the findings.

Participant Demographics

Eight patients with pulmonary aspergilloma, including six with inactive disease and two with active disease.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication